BioAffinity Technologies Inc
BIAF
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.57M
Close$
$0.13
93.1% downside
Current Fair Value
93.1% downsideOvervalued by 93.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.57 Million |
|---|---|
| Enterprise Value | $5.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.66 |
| Beta | -1.19 |
| Outstanding Shares | 4,494,752 |
Return
| Return on Equity | -433.71% |
|---|---|
| Return on Assets | -199.87% |
| Return on Invested Capital | -242.70% |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | -1.3 |
| Price to Sales | 1.88 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | -0.51 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-2.40
Average shareholder expectationRevenue Estimate
$1.48 M
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-2.10
Average shareholder expectationRevenue Estimate
$1.70 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.39%▲ 0.83% |
|---|---|
| Total Invested | $928,482▲ 903.34% |
| Investors Holding | 14▲ 5.00% |
ESG Score
No data